Neuroscience

Investigational drug may reduce involuntary movements

Results of the first randomized, placebo-controlled long-term clinical trial show the investigational drug safinamide may reduce dyskinesia or involuntary movements in mid-to-late stage Parkinson's disease. The findings will ...

Psychology & Psychiatry

New medication significantly decreases involuntary movement

Antipsychotic treatment can cause involuntary movements such as lip smacking, tongue protrusions and excessive eye blinking. These movements typically occur after more than 3 months of treatment and are called tardive dyskinesia.

Psychology & Psychiatry

Computers can tell if you're bored, says new study

Computers are able to read a person's body language to tell whether they are bored or interested in what they see on the screen, according to a new study led by body-language expert Dr Harry Witchel, Discipline Leader in ...

page 1 from 2